По вашему запросу найдено документов: 1356

Страница 1 из 136

НЕФЕРМЕНТАТИВНОЕ ЗВЕНО АНТИОКСИДАНТНОЙ ЗАЩИТЫ КОСТНОЙ ТКАНИ ПРИ ИНТОКСИКАЦИИ КОМПОНЕНТАМИ МЕДНО-ЦИНКОВОЙ КОЛЧЕДАННОЙ РУДЫ
NON-ENZYMATIC LINK OF BONE TISSUE ANTIOXIDANT PROTECTION DURING INTOXICATION WITH COMPONENTS OF COOPER-ZINC PYRITIC ORE
Г. Р. Давлетгареева, G. R. Davletgareeva, Е. Р. Фаршатова, E. R. Farshatova, Ф. Х. Камилов, F. Kh. Kamilov (Медицинский вестник Башкортостана, №1, 2017)
free thiol groups
SYNTHESIS AND IN VITRO ANTIBACTERIAL ACTIVITY OF NEW C-3-MODIFIED CARBAPENEMS
VALIULLINA, Z.R., GALEEVA, A.M., GIMALOVA, F.A., SELEZNEVA, N.K., KHASANOVA, L.S., MIFTAKHOV, M.S., MAVZYUTOV, A.R (2019)
group of 4-nitrobenzyl (4R)-3-[(diphenylphosphoryl)oxy]-6-[(1R)-1-hydroxyethyl]-4-methyl-7- oxo-1
DIAGNOSIS AND TREATMENT OF MILLER CLASS I GINGIVAL RECESSION USING FREE CONNECTIVE TISSUE AUTOGRAFT FROM THE HARD PALATE. CLINICAL OBSERVATION
Farkhshatova, R, Gerasimova, L, Usmanova, I, Daurova, F, Golub, A, Aletdinova, S (2022)
treatment. The average percentage efficacy of recession coverage in the study group was - 84%. Pain
The impact of cortisol treatment on free radical oxidation in traumatized clean-up workers 30 years after chernobyl nuclear disaster
Tseylikman, V., Davydovich, M., Tseylikman, O., Ullmann, E. (2019)
contact compared with the healthy control group.Exogenous cortisol treatment increases propanol 2-soluble
Rucaparib versus chemotherapy for treatment of relapsed ovarian cancer with deleterious BRCA1 or BRCA2 mutation (ARIEL4): final results of an international, open-label, randomised, phase 3 trial
Oza, Amit M, Lisyanskaya, Alla, Fedenko, Alexander, de Melo, Andreia Cristina, Shparyk, Yaroslav, Rakhmatullina, Irina, Bondarenko, Igor, Colombo, Nicoletta, Svintsitskiy, Valentyn, Biela, Luciano, Nechaeva, Marina, Lorusso, Domenica, Scambia, Giovanni, Cibula, David, Póka, Róbert, Oaknin, Ana, Safra, Tamar, Mackowiak-Matejczyk, Beata, Ma, Ling, Thomas, Daleen, Lin, Kevin K, McLachlan, Karen, Goble, Sandra, Kristeleit, Rebecca (2025)
-assessed progression-free survival with rucaparib. Here, we present the final overall survival analysis of the trial
Rucaparib versus standard-of-care chemotherapy in patients with relapsed ovarian cancer and a deleterious BRCA1 or BRCA2 mutation (ARIEL4): an international, open-label, randomised, phase 3 trial
Kristeleit, Rebecca, Lisyanskaya, Alla, Fedenko, Alexander, Dvorkin, Mikhail, de Melo, Andreia Cristina, Shparyk, Yaroslav, Rakhmatullina, Irina, Bondarenko, Igor, Colombo, Nicoletta, Svintsitskiy, Valentyn, Biela, Luciano, Nechaeva, Marina, Lorusso, Domenica, Scambia, Giovanni, Cibula, David, Póka, Róbert, Oaknin, Ana, Safra, Tamar, Mackowiak-Matejczyk, Beata, Ma, Ling, Thomas, Daleen, Lin, Kevin K, McLachlan, Karen, Goble, Sandra, Oza, Amit M (2022)
patients in the rucaparib group; 105 in the chemotherapy group), median progression-free survival was 7
СРАВНИТЕЛЬНЫЙ АНАЛИЗ ПОЛИМОРФНОГО МАРКЕРА RS1131341 ГЕНА NQO1 В ПОПУЛЯЦИЯХ ИЗ РАЗНЫХ ЭКОЛОГИЧЕСКИХ РЕГИОНОВ
COMPARATIVE ANALYSIS OF THE POLYMORPHIC MARKER RS1131341 OF THE NQO1 GENE IN POPULATIONS FROM DIFFERENT ECOLOGICAL REGIONS
Эрдман, В.В., Насибуллин, Т.Р., Туктарова, И.А., Казанцева, С.Р., Матуа, А.З., Мустафина, О.Е., Полоников, А.В., Викторова, Т.В., Erdman, V.V., Nasibullin, T.R., Tuktarova, I.A., Kazantseva, S.R., Matua, A.Z., Mustafina, O.E., Polonikov, A.V., Viktorova, T.V. (2020)
ethnic group
ANATOMIC MESOHEPATECTOMY VERSUS EXTENDED HEPATECTOMY FOR PATIENTS WITH CENTRALLY LOCATED HEPATOCELLULAR CARCINOMA
Li, W., Li, L., Minigalin, D., Wu, H. (2018)
for these patients by multivariable regression analysis. In addition, the patients in the MH group were matched in a
ОТДАЛЕННЫЕ ОНКОЛОГИЧЕСКИЕ РЕЗУЛЬТАТЫ ЛЕЧЕНИЯ БОЛЬНЫХ РАКОМ ПРЕДСТАТЕЛЬНОЙ ЖЕЛЕЗЫ ВЫСОКОГО РИСКА (T3)
LONG-TERM ONCOLOGICAL RESULTS OF TREATMENT OF PATIENTS WITH HIGH-RISK PROSTATE CANCER (T3)
Воздвиженский, М.О., Горбачев, А.Л., Исаргапов, Р.М., Vozdvizhensky, M.O., Gorbachev, A.L., Isargapov, R.M. (2021)
disease-free survival
COLTSFOOT LEAVES (TUSSILAGO FARFARA L.) A PROMISING SOURCE OF ESSENTIAL AMINO ACIDS
CHROMCHENKOVA, E.P., BOKOV, D.O., BESSONOV, V.V., SAMYLINA, I.A., KAKHRAMANOVA, S.D., CHEVIDAEV, V.V., SOKHIN, D.M., BALOBANOVA, N.P., EVGRAFOV, A.A., KRASNYUK, J.I., KUDASHKINA, N.V., GALIAKHMETOVA, E.K., MARAKHOVA, A.I., MOISEEV, D.V. (2020)
Objective: Free and bounded amino acids are one of the valuable biologically active substances (BAS

Страница 1 из 136

Google Scholar
OpenDoar

Фасеты

Научный руководитель
Авторы
Ключевые слова
Год